| scholarly article | Q13442814 |
| P356 | DOI | 10.2217/FON-2017-0515 |
| P698 | PubMed publication ID | 28589742 |
| P50 | author | Yongchang Wei | Q59693622 |
| Tianhe Huang | Q85687209 | ||
| P2093 | author name string | Yan Lin | |
| Kejun Nan | |||
| Jie Lian | |||
| Zongfang Li | |||
| Chengge Gao | |||
| Fuling Zhou | |||
| Lingyun Hui | |||
| Honglei Tu | |||
| P2860 | cites work | Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta-analysis of 64,196 patients | Q27853207 |
| Long-term Follow-up Data from Pivotal Studies of Adjuvant Trastuzumab in Early Breast Cancer. | Q30371966 | ||
| 12-month outcomes of community engagement versus technical assistance to implement depression collaborative care: a partnered, cluster, randomized, comparative effectiveness trial | Q34532654 | ||
| Baseline psychosocial predictors of survival in localised breast cancer | Q35551141 | ||
| Psychosocial Predictors and Outcomes of Delayed Breast Reconstruction in Mastectomized Women in Mainland China: An Observational Study | Q35862166 | ||
| Polymorphism at 19q13.41 Predicts Breast Cancer Survival Specifically after Endocrine Therapy | Q36071595 | ||
| Association of breast cancer risk loci with breast cancer survival | Q36191018 | ||
| The relationship between tumour budding, the tumour microenvironment and survival in patients with invasive ductal breast cancer | Q36295024 | ||
| The effect of psychosocial factors on breast cancer outcome: a systematic review | Q36393259 | ||
| Value of Breast Cancer Molecular Subtypes and Ki67 Expression for the Prediction of Efficacy and Prognosis of Neoadjuvant Chemotherapy in a Chinese Population | Q36891801 | ||
| Network Meta-Analysis of the Effectiveness of Neoadjuvant Endocrine Therapy for Postmenopausal, HR-Positive Breast Cancer | Q36897982 | ||
| The Extent of Axillary Surgery Is Associated With Breast Cancer-specific Survival in T1-2 Breast Cancer Patients With 1 or 2 Positive Lymph Nodes: A SEER-Population Study | Q37206704 | ||
| Tumor characteristics as predictors of local recurrence after treatment of ductal carcinoma in situ: a meta-analysis | Q37843725 | ||
| Major depressive disorder in breast cancer: a critical systematic review of pharmacological and psychotherapeutic clinical trials | Q38148369 | ||
| Efficacy and acceptability of antidepressants on the continuum of depressive experiences in patients with cancer: Systematic review and meta-analysis. | Q38539258 | ||
| Molecular Mechanisms Underlying Lymphovascular Invasion in Invasive Breast Cancer | Q38578695 | ||
| A phase II trial of abiraterone acetate plus prednisone in patients with triple-negative androgen receptor positive locally advanced or metastatic breast cancer (UCBG 12-1). | Q38800053 | ||
| An overview of the effective combination therapies for the treatment of breast cancer | Q38830610 | ||
| Cancer statistics in China, 2015. | Q40064386 | ||
| Survival impact and predictive factors of axillary recurrence after sentinel biopsy | Q40857106 | ||
| Is the TNM staging system for breast cancer still relevant in the era of biomarkers and emerging personalized medicine for breast cancer - an institution's 10-year experience | Q41562136 | ||
| Oxidative stress in depressive patients with gastric adenocarcinoma. | Q43503650 | ||
| Reducing treatment decision conflict difficulties in breast cancer surgery: a randomized controlled trial. | Q45304369 | ||
| Benefit finding predicts depressive and anxious symptoms in women with breast cancer | Q47695477 | ||
| Poor-prognosis disclosure preference in cancer patient-caregiver dyads and its association with their quality of life and perceived stress: a cross-sectional survey in mainland China | Q47890057 | ||
| 5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial. | Q48055457 | ||
| The presence of extensive retraction clefts in invasive breast carcinomas correlates with lymphatic invasion and nodal metastasis and predicts poor outcome: a prospective validation study of 2742 consecutive cases | Q48819674 | ||
| Prognostic value of a combined estrogen receptor, progesterone receptor, Ki-67, and human epidermal growth factor receptor 2 immunohistochemical score and comparison with the Genomic Health recurrence score in early breast cancer. | Q50510241 | ||
| Psychosocial predictors of survival in metastatic melanoma. | Q51084568 | ||
| Molecular phenotypes of DCIS predict overall and invasive recurrence. | Q53617890 | ||
| P433 | issue | 17 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | major depressive disorder | Q42844 |
| P304 | page(s) | 1493-1503 | |
| P577 | publication date | 2017-06-07 | |
| P1433 | published in | Future Oncology | Q2781597 |
| P1476 | title | Potential prognostic value of clinical characteristics, hormone status and major depressive disorder in breast cancer | |
| P478 | volume | 13 |
| Q90230957 | Correlation of Clinicopathological Characteristics of Breast Carcinoma and Depression |
| Q92618208 | Epinephrine increases malignancy of breast cancer through p38 MAPK signaling pathway in depressive disorders |
| Q92511862 | Reactive Oxygen Species Are Involved in the Development of Gastric Cancer and Gastric Cancer-Related Depression through ABL1-Mediated Inflammation Signaling Pathway |
Search more.